InnerScope Hearing
Technologies
(OTC: INND) Announces
Profitable Year-End 2022 Financial Results
Full-Year
2022 Financial Highlights:
-
Consolidated
Net Revenues: $15,284,327
-
Gross
Profit: $9,079,335
-
Net
Profit: $5,575,892
-
Net
Profit from Operations: $909,135
-
Positive
EBITA of
36%
ROSEVILLE, CA -- April 3,
2023 -- InvestorsHub NewsWire -- InnerScope
Hearing Technologies Inc. (OTC:
INND) ("InnerScope"), an emerging and disruptive leader in the
Over-the-Counter (OTC) hearing aid space, announced today its
unaudited financial results for the full year ended December 31,
2022 ("2022 Full-Year"). InnerScope reported consolidated net
revenues of
$15,284,327,
with a net profit
of
$5,575,892 and a
positive EBITA (Earnings Before Taxes) of
36% for the 2022
Full-Year.
InnerScope's
annual financial report has been filed with the OTC Markets and is
available to view at:
https://www.otcmarkets.com/otcapi/company/financial-report/363918/content
Full-Year 2022 Financial Result Highlights
-
Consolidated Net Revenues
of
$15,284,327 were
largely driven by wholesale distribution agreements from
InnerScope's acquisitions of Hearing Assist II Inc.
("HearingAssist") and iHear Medical Inc. ("iHEAR") in late 2021.
HearingAssist was Walmart's largest supplier of hearing aids online
and in selected stores, and iHEAR has a team of electrical and
biomedical engineers, hearing aid-related patents, and wholesale
partners.
-
Gross Profit of
$9,079,335 is from an
increase in gross margin with suppliers from a substantially
increased number of hearing aids sold, which resulted in providing
better technology at a lower price.
-
Profit from Operations
of
$909,135 is from a
substantial increase in the number of hearing aids
sold.
-
Net Profit of
$5,575,892 is
primarily from the gain on debt extinguishment and derivative
liability.
-
Positive EBITA of
36%
"This profitable year-end
2022 shows we are on the right path continuing to scale and support
our growth, especially now with our success with numerous major
retailers requesting to sell our products," said Matthew Moore, CEO
of InnerScope Hearing Technologies." Our B2B strategy and the
retailer relationships we built over the last year created strong
momentum that will continue through 2023 and
beyond. With only a hand full of competitors
in this new emerging OTC hearing aid market, we are confident that
we can continue to deliver our high-quality affordable OTC hearing
aids to the ever-growing demand from all the retailers."
2022 Business Highlights
-
Developed and launched
four new models of OTC Rechargeable Hearing Aids for both the
HearingAssist and iHEAR brands.
-
Expanded Wholesale
Distribution of
HearingAssist Brand of OTC Hearing Aids to:
-
1500+ Walmart Vision
Centers, CVS.com, BestBuy.com, RiteAid.com
-
Expanded Wholesale
Distribution of
iHEAR Brand of
OTC Hearing Aids to:
-
CVS.com,
AmerisourceBergen, Cardinal Health, Cardinal Health at Home, Topco
& Associates, Carewell.com, Hy-Vee, Hartig Drug, Wakefern Food
Corp, Spartan Nash
-
Created and deployed
Free-Standing and Counter-Top Product Displays within 1500+ Walmart
Vision Centers.
-
Deployed 118 more
InnerScope's first-generation automated point-of-sale
self-administered
Hearing Screening Kiosks in pharmacies nationwide. The Hearing
Screening Kiosks provide customers to take a free 3 to 5-minute
hearing screening test and receive instant results on screen or can
be emailed plus information on iHEAR or HearingAssist OTC Hearing
Aid products available to purchase at the store and/or through the
retailer's online sales portal.
-
Created and launched
an
Online Hearing Screening Test version for the retailers' websites,
the same Hearing Screening Test as in the automated point-of-sale
self-administered Hearing Screening Kiosks.
-
Created an Internal
Hearing Care Professional Customer Service Call Center staffed with
Doctors of Audiology and Licensed Hearing Aid Dispensers to provide
enhanced customer service.
-
Deployed 500 Pharmacy
Counter Placards and Product Brochures to
AmerisourceBergen
Strategic
Growth Update: Continue Progress in Growing Wholesale
Distribution
2022 was the year of the
long-awaited historic
FDA ruling enacted on October 17, 2022, enabling
access to over-the-counter hearing aids for millions of Americans
to be sold in retail stores and pharmacies without a prescription
or seen by a hearing health professional. The FDA ruling created a
new emerging OTC hearing aid market that was a game changer for
InnerScope. As a result of the FDA ruling, InnerScope has pivoted
from a direct-to-consumer hearing aid company with its
business-to-consumer ("B2C") sales model to primarily a
business-to-business ("B2B") sales model. InnerScope's pivot to the
B2B model has resulted in major growth in developing a wholesale
distribution network of major retailers, pharmacy chains, and
healthcare service companies (i.e., Cardinal Health and
AmerisourceBergen). Moreover, InnerScope's B2B sales
model allows more focus and resources for retailer marketing and
training retailers on delivering a positive buying experience for
InnerScope's OTC Hearing Aids at the store level to their
customers. In addition, InnerScope provides the retailer's
customers with expert help from its internal Hearing Care
Professional Customer Service Call Center.
In the first quarter of
2023, InnerScope continues its B2B growth trajectory by adding
another major retailer with the announcement
of its HearingAssist Brand on Target.com.
InnerScope has also delivered 2000+
Pharmacy Counter Placards with Product Brochures to Cardinal Health
to be distributed to its pharmacy network. Additionally, InnerScope
has deployed 17 of its newly designed second-generation automated
point-of-sale self-administrated Hearing Screening Kiosks to
pharmacies, and 98 more are scheduled to be delivered in the next
two weeks. Currently, InnerScope is shipping products and
free-standing product displays to 1700+ locations for one of its
major retailers.
SEC Audit Update
InnerScope, as previously
announced, retained the audit services of CPA firm Kreit & Chiu
CPA LLP ("KC Auditors") to perform independent audits of the
financials. The KC Auditors are expected to finish the 2021 and
2022 annual financials in Q2 2023. Once the audits 2021 and 2022
annual financial audits are completed, InnerScope intends to file a
Form-10 to be upgraded from OTC Alternative Reporting to SEC
Reporting status after 60 days from the date of filing.
As a result of the 2021
annual financial audit, adjustments to the revenue recognition,
derivative income, and derivative liability were made, which
resulted in a change in net income for 2021 from a Net Loss
of $55,213,992 that
was previously reported to a Net Income
of $3,366. This
positive change totaled $55,217,358, partly due to InnerScope's
acquisition of HearingAssist and iHEAR that same year.
About InnerScope Hearing Technologies, Inc.
(OTC PINK: INND):
InnerScope Hearing Technologies Inc. is a manufacturer and distributor of
OTC Hearing Aids, Hearing Aid Accessories & Hearing
Health-Related Products ("Hearing Products") dedicated to
addressing the global demand for affordable hearing solutions.
InnerScope's, with its B2B business distribution model offering
affordable OTC Hearing Products through major retailers, pharmacy
chains, and healthcare service companies, breaks through the
barriers that prevent access to effective and affordable hearing
solutions.
In September 2021, InnerScope
acquired iHear Medical Inc., a Direct-to-Consumer ("DTC")
cloud-based hearing solution provider, which provided access to
over 40 patents and an R&D facility, and a team of engineers.
In addition, InnerScope, in November 2021, also
acquired HearingAssist,
an established leader
since 2008 in the DTC hearing aid market with a customer base of
over 400,000. These acquisitions, combined with a partnership
with
Atlazo Inc.,
a semiconductor innovator
for next-generation AI smart devices, will allow InnerScope to
better position itself in the OTC hearing aid market by selling
advanced and affordable Hearing Products through Walmart and many
other major retailers and pharmacy chains.
InnerScope's full line of
its HearingAssist and iHEAR branded Hearing Products is currently
available through these multiple retail/wholesale distribution
channels:
Walmart Vision Centers,
Walmart.com,
Walmart Canada,
CVS.com,
RiteAid.com,
Target.com,
BestBuy.com,
Amazon.com,
AmerisourceBergen,
Cardinal Health,
Cardinal Health™ at-Home,
Carewell.com
FSAStore.com,
HSAStore.com,
WellDeservedHealth.com,
Fingerhut.com,
Giant Eagle /
Hy-Vee /
Hartig Drug /
Food City /
Wakefern Food Corp. / ShopRite
/
SpartanNash /
VG's Grocery /
Family Fare /
Martin's Super Markets
/
Kholl's Pharmacy & Homecare and
Topco Associates representing 15,000+ store
locations.
Coming
Soon: More major
retailers and pharmacy chains for in-store and online HearingAssist
and iHEAR branded Hearing Products.
For information related
to InnerScope Hearing Technologies' latest hearing aids and related
hearing products, please visit:
http://iheardirect.com
http://hearingassist.com
For the most up-to-date
information about InnerScope Hearing Technologies OTC: $INND,
please visit and follow our official Twitter account @inndstock
page:
https://twitter.com/inndstock
InnerScope
Hyperlinks:
HearingAssist
HearingAssist - Walmart.com
HearingAssist – Target.com
HearingAssist - CVS.com
HearingAssist - RiteAid.com
HearingAssist - BestBuy.com
iHEAR
iHEAR - CVS.com
AmerisourceBergen,
Cardinal Health,
Cardinal Health™ at-Home,
Carewell.com
FSAStore.com,
HSAStore.com,
WellDeservedHealth.com,
Fingerhut.com,
Giant Eagle /
Hy-Vee /
Hartig Drug /
Food City /
Wakefern Food Corp. / ShopRite
/
SpartanNash /
VG's Grocery /
Family Fare /
Martin's Super Markets
/
Kholl's Pharmacy & Homecare,
Topco Associates
Acquisition of iHear Medical Inc.
Acquisition of HearingAssist
Safe
Harbor
This news release
contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended intended to be
covered by the "safe harbor" created by those sections. Any
statements that are not historical facts contained in this press
release are also "forward-looking statements" as that term is
defined under the Private Securities Litigation Reform Act of 1995
(PSLRA). Such statements may be identified by words such as
"expects," "plans," "projects," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of
similar meaning. Such forward-looking statements are based on
current expectations, involve known and unknown risks, a reliance
on third parties for information, transactions or orders that may
be cancelled, and other factors that may cause our actual results,
performance or achievements, or developments in our industry, to
differ materially from the anticipated results, performance or
achievements expressed or implied by such forward-looking
statements. Factors that could cause actual results to differ
materially from anticipated results include risks and uncertainties
related to the fluctuation of global economic conditions, the
performance of management and our employees, our ability to obtain
financing or maintain contractual relationships with vendors and
customers, competition, general economic conditions and other
factors that are detailed in our periodic reports filed with the
Securities and Exchange Commission ("SEC"). We intend that all
forward-looking statements be subject to the safe-harbor provisions
of the PSLRA, Securities Act and Securities Exchange
Act.
Contact:
InnerScope Hearing
Technologies, Inc.
Investor
Relations
ir@innd.com
833-788-0506
www.innd.com
Investor
Relations Agency Contact:
Skyline Corporate Communications
Group, LLC
Lisa Gray, Senior Account
Manager
One Rockefeller Plaza, 11th
Floor
New York, NY
10020
Office: (646)
893-5835
Email: lisa@skylineccg.com